Breathe Well Live Well
 CBC.ca |
Fall allergy season starts
Today’s THV Arkansas Allergy & Asthma Clinic in Little Rock has six board certified allergy/asthma specialists available for interviews for medical segments and news stories concerning this important health issue. The American Academy of Allergy Asthma … Atchoo! Battle dust-mite allergies Hit and miss diagnoses Enormously Useful Allergy Treatment – With Virtually No Side Effects |
View full post on asthma – Google News
 Moneycontrol.com |
Glenmark starts Revamilast Phase IIb trials
Pharmaceutical Business Review Indian drug maker Glenmark Pharmaceuticals has started Phase IIb trials to evaluate Revamilast (GRC 4039) as a treatment for inflammatory disorders like rheumatoid arthritis (RA) and asthma. The trials aim to determine the safety and efficacy profile … Glenmark starts Phase-IIb human trials of Revamilast molecule Glenmark starts phase IIb human trials of molecule Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule … |
View full post on asthma – Google News
Moneycontrol.com |
Glenmark starts phase IIb human trials of molecule
mydigitalfc.com Glenmark is positioning Revlimast as a treatment for chronic inflammatory disorders such as asthma and rheumatoid arthritis. Rheumatoid arthritis and asthma drugs are estimated to have a market in excess of $20 billion each. … Glenmark starts Phase-IIb human trials of Revamilast molecule Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule … |
View full post on asthma – Google News
|
Glenmark starts Phase-IIb human trials of Revamilast molecule
Economic Times NEW DELHI: Glenmark Pharmaceuticals on Wednesday said it has started Phase-IIb human trials of its 'Revamilast' molecule, which is being developed for treatment of inflammatory disorders like asthma and rheumatoid arthritis. The Phase-IIb studies of … Glenmark initiates Phase IIb human trials globally for its novel molecule … |
View full post on asthma – Google News
|
Verona Pharma starts asthma drug Phase II trial
Pharmaceutical Business Review Verona Pharma has started a Phase II trial of its respiratory drug RPL554 to determine if the drug has sustained bronchodilator actions, and is safe when given daily to patients who are suffering from mild asthma. The company has also treated first … Verona Pharma starts new trial of lead drug |
View full post on asthma – Google News
|
Targacept starts new trial for diabetes drug
Bizjournals.com Targacept will take a drug it hopes will become a treatment for asthma and Type 2 diabetes into a Phase 2 clinical trial, the company has announced. … Targacept to begin phase 2 trials for its anti-inflammatory drug compound TARGACEPT : Announces Initiation of Phase 2 Studies of TC-6987 in Asthma and … |
View full post on asthma – Google News
 Proactive Investors UK |
Verona Pharma starts Asthma drug trial
Proactive Investors UK Verona Pharma (LON:VRP) has begun a new clinical trial to evaluate higher dosing of its key asthma drug, RPL554. The trial will help Verona set the dosage … |
View full post on asthma – Google News